Delivery Order SPE2DR25D3301-SPE2DR26F23CA
Award Date 2/26/26
Potential Completion Date 3/19/26
Potential Value $36K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of HEMLIBRA 105 mg/0.7 mL vials totaling $6,168.26. This is a firm fixed-price delivery order with no set-aside designation, demonstrating competitive award authority. The order is scheduled for completion by August 29, 2025, with performance taking place at AmerisourceBergen's corporate facility in Conshohocken, Pennsylvania. HEMLIBRA is a specialty pharmaceutical product...
- The Defense Logistics Agency awarded a $17,634.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HEMLIBRA 150 mg/mL vials on August 25, 2025. This non-set-aside contract is scheduled for completion by September 16, 2025, with performance at the contractor's Conshohocken, Pennsylvania facility. HEMLIBRA is a specialized hemophilia A therapeutic product, reflecting the pharmaceutical distributor's role in supplying critical medications to support military and federal healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $26,451.57 to AmerisourceBergen Drug Corp for the supply of HEMLIBRA 150 mg/ml vials. This firm fixed price contract, issued on September 2, 2025, with an ultimate completion date of September 23, 2025, represents a competitive award with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the pharmaceutical distributor maintains its...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HEMLIBRA 150 MG/ML vial, a medication, with a ceiling value of $8,817.19 and a period of performance through July 7, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with DLA Troop...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $3,571.69 by the Defense Logistics Agency on January 30, 2026, with an ultimate completion date of February 23, 2026. The contract calls for the delivery of HEMLIBRA 60 mg/0.4 ml vials (0.4 ml) and was awarded competitively without set-aside provisions. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $35,268.76 firm fixed price delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of HEMLIBRA 150 mg/ml vials. This non-competitive delivery order, with an ultimate completion date of June 3, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 master pharmaceutical supply vehicle running through December 2026. The performance...
- This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,451.57, is for the delivery of HEMLIBRA 150 MG/ML VIAL and is a Firm Fixed Price Delivery Order. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $31,753.90 to AmerisourceBergen Drug Corp for the supply of Hemlibra 105 mg/0.7 mL vials. This non-competitive, firm fixed-price delivery order was issued on November 17, 2025, with an ultimate completion date of December 9, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Hemlibra 60 mg/0.4 ml vials, a specialized pharmaceutical product used in hemophilia treatment. This firm fixed-price delivery order, valued at $7,376.94, is scheduled for completion by January 6, 2026, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award represents a competitive, non-set-aside procurement conducted under an existing contract vehicle,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $24,673.08 to AmerisourceBergen Drug Corp for the supply of Hemlibra 105 mg/0.7 mL vials. This firm fixed-price, non-set-aside contract was executed on May 30, 2025, with an ultimate completion date of June 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Hemlibra is a bispecific monoclonal antibody used in the treatment of hemophilia A and B, representing a...